BioSyent Inc. (CVE:RX) stock is about to trade ex-dividend in four days. The ex-dividend date is usually set to be one business day before the record date which is the cut-off date on which you must ...

Biosyent ( (TSE:RX)) has provided an announcement. BioSyent Inc. has scheduled the release of its financial results for the third quarter and year-to-date 2025 on November 20, 2025, after market hours ...

Pursuant to the SPA, BioSyent will acquire from the shareholders of Oral Science (the “Sellers”), in an arm’s length transaction, 100% of the issued and outstanding shares of Oral Science Inc. for a ...

MISSISSAUGA, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months and six months ended June ...

Return on Average Equity for TTM September 30, 2025 was 22% as compared to 20% for TTM September 30, 2024 During YTD 2025, repurchased for cancellation a total of 19,500 common shares under a Normal ...

BioSyent Inc. (TSXV:RX) released its Q1 2025 financial results on May 15, 2025, revealing substantial growth across key metrics. The pharmaceutical company, which trades near $10.77 per share, ...

"BioSyent delivered strong third quarter financial results,” commented Mr. René Goehrum, President and CEO of BioSyent. "Each of our three businesses performed well during the quarter, with total ...